Price target upside
20/20 Biolabs, Inc. Price Target Upside or Downside
AIDX price target upside based on the current price and analyst average.
Direct answer
20/20 Biolabs, Inc.'s analyst target implies +863.4%.
The average target is $5.00 compared with a recorded current price of $0.52.
This percentage is calculated from the verified average target and recorded market price.
Forecast evidence checked August 14, 2026.
Get free 20/20 Biolabs, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $0.52
- Average price target
- $5.00
- High price target
- $5.00
- Low price target
- $5.00
- Target upside
- +863.4%
- Consensus rating
- none
- Analysts
- 1
- Evidence date
- August 14, 2026
- Valid through
- August 21, 2026